mizoribine has been researched along with Dry Eye Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Hu, J; Huang, C; Li, W; Lin, X; Liu, Z; Ouyang, W; Tang, L; Wu, J; Wu, Y; Yang, Y; Zhang, X; Zheng, X; Zhou, Y | 1 |
| Li, W; Lin, X; Liu, Z; Ouyang, W; Wu, Y; Yang, Y; Zhang, X | 1 |
2 other study(ies) available for mizoribine and Dry Eye Syndromes
| Article | Year |
|---|---|
Comparison of Treatment Effect and Tolerance of the Topical Application of Mizoribine and Cyclosporine A in a Mouse Dry Eye Model.
Topics: Animals; Cyclosporine; Dry Eye Syndromes; Mice; Mice, Inbred C57BL; Oregon; Ribonucleosides | 2020 |
Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
Topics: Administration, Ophthalmic; Animals; Apoptosis; CD4-Positive T-Lymphocytes; Disease Models, Animal; Dry Eye Syndromes; Epithelium, Corneal; Female; Immunity, Cellular; Immunohistochemistry; Immunosuppressive Agents; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Ribonucleosides; Tears | 2017 |